ReNAgade Therapeutics Launches with $300 Million in Series A Financing

Posted by ISPE Boston
On June 27, 2023

RNA medicines biotech ReNAgade Therapeutics has raised $300 million in a Series A financing round led by MPM BioImpact and F2 Ventures. ReNAgade has built a comprehensive and complementary platform that combines its proprietary delivery technologies, including novel lipid nanoparticles (LNPs), with a broad array of coding, editing, and gene insertion tools, in an all-RNA […]

Biogen/Eisai Alzheimer Drug Wins Favorable Vote from FDA Advisory Committee

Posted by ISPE Boston
On June 15, 2023

Biogen and partner Eisai have announced that the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted unanimously that the data from Eisai’s Phase 3 Clarity AD clinical trial confirms the clinical benefit of Leqembi (lecanemab-irmb) for the treatment of Alzheimer’s disease (AD). Additionally, the committee members confirmed the overall benefit-risk profile of Leqembi, the […]

Life Sciences Workforce Initiative Launched in Boston

Posted by ISPE Boston
On June 15, 2023

At the opening of the BIO International Convention, Mayor Michelle Wu announced a new City workforce initiative to train and employ Boston residents in life sciences careers. With recent industry reports from the MassBio and MassBioEd highlighting continued job growth in the industry, Mayor Wu announced her goal to help 1,000 Boston residents get trained and hired into […]

Governor Healey Pledges Support for Life Sciences Industry at BIO Convention

Posted by ISPE Boston
On June 15, 2023

At the BIO International Convention, Governor Maura Healey announced that her administration is launching a new strategy for connecting employers to skilled, diverse workers in Massachusetts called MassTalent which will serve as a one-stop front door for companies to access multiple talent pipelines in high-growth industries like the life sciences, clean energy and advanced manufacturing. To […]

Thoughts from the May Meeting: The Current State of DE&I in Pharma/Biotech

Posted by Eric Felz
On June 15, 2023

On Thursday May 18th, ISPE Boston Chapter teamed up with the Color of Biotech and one of Takeda’s Resource Groups – Black Leadership Council (BLC) to present ‘The Current State of Diversity, Equity and Inclusion in the pharmaceutical industry’ hosted at Takeda in Kendall Square. The event opened with networking and a wonderful view of […]

Chapter Member Anniversaries: June 2023

Posted by ISPE Boston
On June 2, 2023

Please congratulate the following members celebrating milestone anniversaries in June 2023. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Francisco Buot, Commissioning Agents Robert Cole, Hart Design Group Timothy Horgan, Alnylam Pharmaceuticals David Hyde, Lantheus Holdings, Inc. Richard Kotosky, Kotosky Consulting LLC Kevin Mitchell, TEK Stainless Piping […]

Welcome New Members May 2023!

Posted by ISPE Boston
On June 2, 2023

We would like to introduce the Members who joined ISPE in May 2023, welcome them to the Chapter and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth

Posted by ISPE Boston
On June 1, 2023

ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering the creation of life-transforming cell and gene therapies, announced the closing of its $401 million Series D financing led by the AyurMaya Capital Management Fund, managed by Matrix Capital Management, and joined by a leading group of new and existing investors. ElevateBio’s syndicate now includes new […]

Novo Nordisk and Life Edit Therapeutics Establish Multi-Target Collaboration

Posted by ISPE Boston
On June 1, 2023

Novo Nordisk and Life Edit Therapeutics, Inc., an ElevateBio company focused on next-generation gene editing technologies and therapeutics, today announced a research and development collaboration to discover and develop gene editing therapies against a select set of therapeutic targets. With a focus on advancing base editing capabilities, Novo Nordisk will leverage Life Edit’s suite of […]

Congratulations to our Spring Membership Promo Winners

Posted by ISPE Boston
On May 31, 2023

Please join us in welcoming our new members! Our Spring Membership Drive has concluded and we’d like to congratulate the first twenty-five that registered! They have won an ISPE beach towel AND an ISPE stainless-steel wine mug. They’re perfect for these rising temperatures and days at the beach! Our members receive special pricing for chapter […]

Page 21 of 118«‹19 202122 23 ›»